Augtyro 00003-4040-60
Generic: Repotrectinib
- Manufacturer
- E.r. Squibb & Sons, L.l.c.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 5, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA218213
Need to source Augtyro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Repotrectinib | 40 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Cytochrome P450 3A4 Inducers [MoA]Kinase Inhibitor [EPC]
Selected Package
00003-4040-60Selected60 CAPSULE in 1 BOTTLE (0003-4040-60)
Other packages for this product(1)
120 CAPSULE in 1 BOTTLE (0003-4040-12)